학술논문

A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors
Document Type
Article
Source
In: Cancers. (Cancers, March 2024, 16(6))
Subject
Language
English
ISSN
20726694